BioCentury
ARTICLE | Distillery Therapeutics

Cancer

May 31, 2017 4:58 PM UTC

Cell culture and mouse studies identified a JAG2-targeting MT-TL1 fragment that could help treat colorectal cancer. The fragment consisted of a dicer 1 ribonuclease type III (DICER1)-cleaved form of M...